Anticancer Research

Visit the official website of the International Institute of Anticancer Research

Current Issue

February 2026 (Vol. 46 Issue 2) Table of Contents

Issue highlights

Coumarin-based Oximes Exert Monoamine Oxidase Inhibitory Activity
The miR-29b Byproduct MIRTX Shows Superior Anti-tumor Activity, Compared to miR-29b-3p, in Pancreatic Cancer Cells
Geographic Variations in Demographics, Socioeconomic Status, and Stage at Diagnosis Among Hormone Receptor–positive Invasive Ductal Carcinoma: An NCDB Analysis (2004-2020)
Describing the Mutational Characteristics of Myxofibrosarcoma: An AACR Project GENIE Analysis
Polymorphisms of FGFR Pathway-related Factors and Capecitabine-induced Hand-foot Syndrome in Japanese Patients With Colorectal Cancer

Latest Articles

You have access
Targeting mTOR Signaling in Cancer: The Promise of Natural Product-derived Inhibitors
PITHI CHANVORACHOTE, CHATCHAI CHAOTHAM, ZIN ZIN EI and PREEDAKORN CHUNHACHA

Anticancer Research February 2026, 46 (2) 553-568; DOI: https://doi.org/10.21873/anticanres.17969
You have access
Treatment Patterns and Prognostic Factors of Anti-HER2 Therapy in HER2-positive Advanced/Recurrent Gastric Cancer
NORIKO WADA, YUKINORI KUROKAWA, TSUYOSHI TAKAHASHI, TAKURO SAITO, TAKAOMI HAGI, SHIGETO NAKAI, KOTA MOMOSE, KOTARO YAMASHITA, KOJI TANAKA, TOMOKI MAKINO, HIDETOSHI EGUCHI, YUICHIRO DOKI and TAROH SATOH

Anticancer Research February 2026, 46 (2) 949-961; DOI: https://doi.org/10.21873/anticanres.18001
You have access
Postmenopausal Stage IV Ovarian Yolk Sac Tumor With Neuroendocrine Features: Report of a Rare Case
STEFANO FUCINA, LUCIA LERDA, MICHELE BARTOLETTI, ALESSANDRA PERIN, VINCENZO CANZONIERI and ANTONINO DITTO

Anticancer Research February 2026, 46 (2) 1167-1172; DOI: https://doi.org/10.21873/anticanres.18019
You have access
Targeted Sensitization of Leukemic T-cells to Anticancer Drugs by SIRT1 Agonist SRT-1720
DONIKA IVANOVA, DESSISLAVA LAZAROVA, ZHIVKO ZHELEV, BILIANA NIKOLOVA, VASIL HADJIDEKOV, PLAMEN GETSOV and RUMIANA BAKALOVA

Anticancer Research February 2026, 46 (2) 713-725; DOI: https://doi.org/10.21873/anticanres.17981
You have access
Prognostic Impact of Claudin18.2 and TROP2 Expression in Advanced Gastric Cancer Treated With Nivolumab
TAKAHITO AWATSU, TORU KADONO, HIROKAZU SHOJI, TOSHIHARU HIROSE, HIDEKAZU HIRANO, NATSUKO OKITA, ATSUO TAKASHIMA, AKIHITO NAGAHARA and KEN KATO

Anticancer Research February 2026, 46 (2) 1021-1035; DOI: https://doi.org/10.21873/anticanres.18006
Open Access
Clinical Parameters and Radiomics of Vestibular Schwannomas in NF2-related Schwannomatosis
NINA BOE, VICTOR-F. MAUTNER, REINHARD E. FRIEDRICH, SAID C. FARSCHTSCHI, LASSE DÜHRSEN, HANNO S. MEYER and JOHANNES A. KOEPPEN

Anticancer Research February 2026, 46 (2) 847-856; DOI: https://doi.org/10.21873/anticanres.17992

Visit the official website of Anticancer Research.

Main menu

User menu

Search

Visit the official website of the International Institute of Anticancer Research

Current Issue

Issue highlights

Featured Articles

Latest Articles